Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease (Q42045858)

15 October 2017

Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease (English)

1 reference

15 October 2017

Shoko Kuriyama

1

1 reference

15 October 2017

Yoshiyuki Miwa

2

1 reference

15 October 2017

Hideki Fukushima

3

1 reference

15 October 2017

Hironori Nakamura

4

1 reference

15 October 2017

Katsuhisa Toda

5

1 reference

15 October 2017

Makoto Shiraki

6

1 reference

15 October 2017

Masahito Nagaki

7

1 reference

15 October 2017

Mayumi Yamamoto

8

1 reference

15 October 2017

Eiichi Tomita

9

1 reference

15 October 2017

Hisataka Moriwaki

10

1 reference

15 October 2017

1 March 2007

1 reference

Journal of Clinical Biochemistry and Nutrition

15 October 2017

1 reference

15 October 2017

40

1 reference

15 October 2017

2

1 reference

15 October 2017

116-122

1 reference

Clinical implications of hepatogenous diabetes in liver cirrhosis

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Both insulin sensitivity and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Association of diabetes mellitus and chronic hepatitis C virus infection.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Metabolic handling of orally administered glucose in cirrhosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Diabetes mellitus in patients with liver cirrhosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Insulin resistance in cirrhosis: evidence for a post-receptor defect.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Prognostic value of Pugh's modification of Child-Turcotte classification in patients with cirrhosis of the liver

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

The ethics and morality of clinical trials in man

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Hepatitis C virus infection and incident type 2 diabetes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Liver cirrhosis and diabetes mellitus

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Glucose resistance contributes to diabetes mellitus in cirrhosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2127229

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation

3 November 2018

1 reference

12 December 2020

Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin

1 reference

12 December 2020

Prognostic significance of diabetes in patients with cirrhosis

1 reference

12 December 2020

Cirrhosis and diabetes: C, the difference

1 reference

12 December 2020

Thrombin-Induced Breakdown of Phosphoinositides in Platelets from Patients with NIDDM

1 reference

12 December 2020

Incidence of altered glucose tolerance in liver cirrhosis

1 reference

12 December 2020

Identifiers

DOI

10.3164/JCBN.40.116

1 reference

15 October 2017

1 reference

15 October 2017

1 reference